中文

← All funding rounds

Achira

United StatesDrug discoveryNew York, United StatesFounded 2023Private

Website · achira.ai ↗

Builds molecular simulation models that mix machine learning with physics and quantum chemistry to generate synthetic data for drug design.

Disclosed total$33M
Rounds on record1
Latest round$33MSeed · 2025-02-21
Last stated valuationNone stated
Investors named4
Research on recordNone yet

Money and evidence

Moneyeach round in US dollars; ≈ converted at its date20252026$33M
Closed round

No research by this company is on the record yet.

Rounds and research, on one timeline

  1. 2025-02-21Seed
    Round

    $33M

    For: grow the team and refine its simulation models

    HiringModels and platform

    Endpoints and Crain's New York broke it but were unreadable; FastForward names Dimension as lead. The Recursive gives the euro figure (EUR 31.54M) at therecursive.com/greek-co-founded-achira-secures-e31-54m-with-nvidia-s-backing/.

    Lead · DimensionAmplify Partners ✓Compound ✓NVentures (NVIDIA) ✓

    Reported by FastForward · fastforward.com.cy ↗

Research entries are the timeline's graded entries that name this company. A level grades one claim, not the company, and a blank can mean the record has not caught up rather than that nothing was published.

See these rounds in the table →

On the investors' own sites

Investors that name this company on their own site, in a portfolio or their own announcement. A ✓ in a round marks the same investor.

Its investors also backed

Other companies on this page whose rounds name the same investor.